Carillon Tower Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$27.4M Hold
234,114
0.17% 185
2020
Q3
$24.3M Buy
234,114
+31,231
+15% +$3.14M 0.32% 100
2020
Q2
$18.6M Sell
202,883
-9,247
-4% -$887K 0.14% 206
2020
Q1
$17.8M Sell
212,130
-8,510
-4% -$905K 0.18% 187
2019
Q4
$25M Sell
220,640
-4,314
-2% -$473K 0.17% 213
2019
Q3
$24.4M Sell
224,954
-43,668
-16% -$4.56M 0.17% 214
2019
Q2
$26.2M Buy
268,622
+59,130
+28% +$5.4M 0.18% 209
2019
Q1
$19.1M Buy
209,492
+25,303
+14% +$2.26M 0.14% 250
2018
Q4
$16.8M Buy
184,189
+13,546
+8% +$1.27M 0.14% 235
2018
Q3
$16.8M Sell
170,643
-3,428
-2% -$317K 0.12% 259
2018
Q2
$14.9M Buy
174,071
+50,691
+41% +$4.23M 0.12% 263
2018
Q1
$9.56M Sell
123,380
-4,895
-4% -$404K 0.07% 308
2017
Q4
$10.4M Buy
+128,275
New +$10.3M 0.11% 206

Other funds holding MDT

Carillon Tower Advisers's MDT Position: Q4 2020 in Review

Carillon Tower Advisers held its Medtronic (MDT) position steady in Q4 2020 at 234,114 shares worth $27.4M. The position accounts for 0.17% of the portfolio, ranked #185.

Carillon Tower Advisers first reported a position in MDT in Q4 2017 and has held it in 13 quarters since. 1,958 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Carillon Tower Advisers held 234,114 shares of Medtronic worth $27.4M as of Q4 2020.
  • Carillon Tower Advisers left its Medtronic share count unchanged in Q4 2020.
  • Medtronic made up 0.17% of Carillon Tower Advisers's portfolio in Q4 2020, its #185 holding.
  • Carillon Tower Advisers first reported a position in Medtronic in Q4 2017 and has held it in 13 quarters since.
  • 1,958 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.